Cargando…
Novel Therapeutic Combination Targets the Growth of Letrozole-Resistant Breast Cancer through Decreased Cyclin B1
As breast cancer cells transition from letrozole-sensitive to letrozole-resistant, they over-express epidermal growth factor receptor (EGFR), mitogen-activated protein kinase (MAPK), and human epidermal growth factor receptor 2 (HER2) while acquiring enhanced motility and epithelial-to-mesenchymal t...
Autores principales: | Patel, Jankiben R., Banjara, Bipika, Ohemeng, Afia, Davidson, A. Michael, Boué, Stephen M., Burow, Matthew E., Tilghman, Syreeta L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097176/ https://www.ncbi.nlm.nih.gov/pubmed/37049472 http://dx.doi.org/10.3390/nu15071632 |
Ejemplares similares
-
Glyceollins Trigger Anti-Proliferative Effects in Hormone-Dependent Aromatase-Inhibitor-Resistant Breast Cancer Cells through the Induction of Apoptosis
por: Walker, Rashidra R., et al.
Publicado: (2022) -
Glyceollin I Reverses Epithelial to Mesenchymal Transition in Letrozole Resistant Breast Cancer through ZEB1
por: Carriere, Patrick P., et al.
Publicado: (2015) -
Quantitative Proteomic Profiling Identifies a Potential Novel Chaperone Marker in Resistant Breast Cancer
por: Gallegos, Karen M., et al.
Publicado: (2021) -
A Novel Allosteric Inhibitor Targets PLK1 in Triple Negative Breast Cancer Cells
por: Patel, Jankiben R., et al.
Publicado: (2022) -
Insulin-Like Growth Factor-1 Signaling Regulates miRNA Expression in MCF-7 Breast Cancer Cell Line
por: Martin, Elizabeth C., et al.
Publicado: (2012)